 | NBP2-30286 | Human Metastatic Cancer to Ovary Tissue MicroArray | 1 Slide | Sign In for Pricing | |
 | BNC942226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUM2226-50 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
 | BNC472226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC943750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3750-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC472225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC042225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNCB3750-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC402226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC882226-500 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC683750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUB2225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUM3750-50 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
 | BNCB2225-100 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC043750-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (FABP5/3750), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | LC814a | Lung cancer tissue array with matched metastatic lymph node | each | Sign In for Pricing | |
| BR1008b | Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result. 100 cases/100 cores, replacing BR1008a-BR1008b | each | Sign In for Pricing | |
| KD603 | Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores | 1 Each | Sign In for Pricing | |
| BRM961a | Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores-BRM961a | each | Sign In for Pricing | |
| ES208a | Esophagus cancer and esophagus tissue array, with metastatic cancer, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing ES208 | 1 Each | Sign In for Pricing | |
| LV8011b | Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a | 1 Each | Sign In for Pricing | |
| KD951a | Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma | each | Sign In for Pricing | |
 | BNC742225-500 | FABP5 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP5-3), CF740 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| LC953 | Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952 | 1 Each | Sign In for Pricing | |
| KD808 | Different stages of kidney cancer tissue array, containing metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 1 Each | Sign In for Pricing | |
| SM208 | Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data | 1 Each | Sign In for Pricing | |
| BR1005b | Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a-BR1005b | each | Sign In for Pricing | |
| MLV801 | Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 1 Each | Sign In for Pricing | |
| ES806 | Metastatic esophageal cancer tissue array, 40 cases/80 cores | 1 Each | Sign In for Pricing | |
| EXOP-105A-1 | MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes | 50 µg | Sign In for Pricing | |
| FMG1001 | Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores | 96 Cases / 100 Cores | Sign In for Pricing | |
| NPC081 | Nasopharyngeal carcinoma tissue microarray, containing 56 cases of nasopharyngeal carcinoma (6 cases contain matched cancer adjacent tissue), 6 cases cancer adjacent tissue, plus 13 metastatic carcinoma, single cores per block | 75 Cases / 81 Cores | Sign In for Pricing | |
| UBD208a | Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 | 64 Cases / 192 Cores | Sign In for Pricing | |
| DCO1003 | Colon cancer with metastatic carcinoma tissue array, including pathology grade, 100 cases/100 cores | 100 Cases / 100 Cores | Sign In for Pricing | |
| OV8010b | Mid-advanced stage ovary cancer tissue array with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV8010 | 80 Cases / 80 Cores | Sign In for Pricing | |
 | CO953 | Colon cancer tissue array with matched normal adjacent and matched or unmatched metastatic carcinoma tissue, including pathology grade, TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a | 39 Cases / 95 Cores | Sign In for Pricing | |
| OV208a | High density ovary cancer and ovary tissue array (1999 WHO classification), with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores, replacing OV208 | 69 Cases / 207 Cores | Sign In for Pricing | |
| MLV801a | Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing MLV801 | 80 Cases / 80 Cores | Sign In for Pricing | |
| CXM481 | Cancer of the cervix paired with metastatic tumors in lymph nodes, 12 cases (1.5mm) | 12 Cases (1.5 mm) | Sign In for Pricing | |
| MBS4380892-01 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.02 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-02 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-03 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| MBS4380892-04 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 5x 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4380892-05 | FABP2 (Marker of Metastatic Potential in Colorectal Cancer) | 5x 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| AFG-ELL-0187 | Human High Metastatic Liver Cancer Cells [MHCC-97H] | > 1x 10^6 Cells / Vial | Sign In for Pricing | |
| AFG-ELL-3500-01 | Culture Medium for Human Highly Metastatic Liver Cancer Cells+Luc [MHCC-97H+Luc] | 125 mL | Sign In for Pricing | |
| AFG-ELL-3500-02 | Culture Medium for Human Highly Metastatic Liver Cancer Cells+Luc [MHCC-97H+Luc] | 500 mL | Sign In for Pricing | |
| AFG-ELL-1506-01 | Culture Medium for Mouse Breast Cancer High Metastatic Cells [MA-891] | 125 mL | Sign In for Pricing | |